Kit for diagnosing alzheimer's disease and pharmaceutical composition for treating alzheimer's disease
AssigneesEisai R&D Management Co., Ltd., Keio University
InventorsHirotaka Watanabe, Hideyuki Okano, Kentaro Takahashi
Life of this patent
Estimating the term…
Abstract
A kit for diagnosing Alzheimer's disease and a pharmaceutical composition for treating Alzheimer's disease are disclosed, in which EDIL3 or a nucleic acid encoding EDIL3 is used as an index or target.
Claims18
-11. (canceled)
A method for screening for a substance that inhibits EDIL3, the method comprising:
- culturing a neuron in a medium containing EDIL3 and a test substance;
- and
- detecting a phenotype of Alzheimer's disease from the neuron.
-20. (canceled)
A method for collecting data for diagnosis of Alzheimer's disease, the method comprising quantifying an mRNA encoding EDIL3, a cDNA complementary to the mRNA, or EDIL3 in a biological sample obtained from a subject.
A method for treating Alzheimer's disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of substance that inhibits EDIL3.
Dependencies are inferred from the claim text.